This document is a publication of a United States patent application (US20260083860A1) related to genome editing technologies. The application, filed on August 19, 2025, by Oscar Alvarez, Ming-Yue Lee, and Blair B. Madison, describes compositions and methods for targeted genetic modifications, including the integration of exogenous polynucleotides and the creation of indels at specific gene loci.

As this is a patent application, it does not impose immediate regulatory obligations. However, granted patents resulting from this application could significantly impact research and development in the pharmaceutical and biotechnology sectors, potentially affecting intellectual property rights and market exclusivity for gene-editing therapies. Companies operating in this space should monitor the progress of this application and related patent filings.